Barclays analyst Matt Miksic maintains $Edwards Lifesciences (EW.US)$ with a buy rating, and maintains the target price at $85.
According to TipRanks data, the analyst has a success rate of 62.2% and a total average return of 7.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Edwards Lifesciences (EW.US)$'s main analysts recently are as follows:
Edwards Lifesciences reported a robust performance in sales and earnings, with the future outlook for Q4 and long-term projections up to 2025 anticipated to sustain the stock's upward trajectory.
The assessment is that it may require several more financial quarters for Edwards Lifesciences to assure investors of the stabilization of its TAVR franchise after the third-quarter report.
Expectations were subdued prior to the release of the quarterly results, and subsequent discussions regarding Q4 and future fiscal years did not dispel concerns of potential decline. Although the slowing Q4 TAVR trends are partially attributable to one-time factors, it remains challenging to counter the notion that TAVR growth may continue to decelerate in the upcoming fiscal year.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
